J Green1, A I Levey. 1. Department of Neurology, Emory University, School of Medicine, Wesley Woods Center, Atlanta, GA 30329, USA. jgreen@emory.edu
Abstract
BACKGROUND: Individuals who have a family history (FH) of Alzheimer disease (AD) or who carry the apolipoprotein E epsilon4 allele are at increased risk for developing AD. Abnormalities in brain event-related potentials (ERPs) have been observed in patients diagnosed as having AD. OBJECTIVE: To determine whether groups of nonsymptomatic, middle-aged individuals at increased risk for AD exhibited ERP changes consistent with this disease. DESIGN: In a case-control study, ERPs were elicited using an auditory oddball paradigm, and a brief neuropsychological battery was administered. SETTING: University laboratory facilities. SUBJECTS: We compared age-matched and education-matched groups with a positive family history (FH+; n = 24) or a negative family history (FH-; n = 23) of AD. Within the FH+ group, subgroups were identified as either carriers of the apolipoprotein E epsilon4 allele (epsilon4+; n = 9) or noncarriers (epsilon4-; n = 8), and these subgroups were compared with the FH- group. MAIN OUTCOME MEASURES: The latency and amplitudes of P3, N2, and P2 components of the ERP were quantified and analyzed statistically. RESULTS: Compared with the FH- group, both the whole FH+ group and the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the P3 component. In addition, the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the N2 component. These changes were observed in the absence of neuropsychological deficits. CONCLUSIONS: The findings indicate that groups at increased risk for developing AD show ERP changes consistent with those observed in patients diagnosed as having AD. The results support accumulating evidence that AD has a preclinical phase and that early detection may be possible.
BACKGROUND: Individuals who have a family history (FH) of Alzheimer disease (AD) or who carry the apolipoprotein E epsilon4 allele are at increased risk for developing AD. Abnormalities in brain event-related potentials (ERPs) have been observed in patients diagnosed as having AD. OBJECTIVE: To determine whether groups of nonsymptomatic, middle-aged individuals at increased risk for AD exhibited ERP changes consistent with this disease. DESIGN: In a case-control study, ERPs were elicited using an auditory oddball paradigm, and a brief neuropsychological battery was administered. SETTING: University laboratory facilities. SUBJECTS: We compared age-matched and education-matched groups with a positive family history (FH+; n = 24) or a negative family history (FH-; n = 23) of AD. Within the FH+ group, subgroups were identified as either carriers of the apolipoprotein E epsilon4 allele (epsilon4+; n = 9) or noncarriers (epsilon4-; n = 8), and these subgroups were compared with the FH- group. MAIN OUTCOME MEASURES: The latency and amplitudes of P3, N2, and P2 components of the ERP were quantified and analyzed statistically. RESULTS: Compared with the FH- group, both the whole FH+ group and the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the P3 component. In addition, the FH+/epsilon4+ subgroup showed abnormal prolongation in the latency of the N2 component. These changes were observed in the absence of neuropsychological deficits. CONCLUSIONS: The findings indicate that groups at increased risk for developing AD show ERP changes consistent with those observed in patients diagnosed as having AD. The results support accumulating evidence that AD has a preclinical phase and that early detection may be possible.
Authors: J M Olichney; S K Morris; C Ochoa; D P Salmon; L J Thal; M Kutas; V J Iragui Journal: J Neurol Neurosurg Psychiatry Date: 2002-10 Impact factor: 10.154
Authors: Sean P Deeny; David Poeppel; Jo B Zimmerman; Stephen M Roth; Josef Brandauer; Sarah Witkowski; Joseph W Hearn; Andrew T Ludlow; José L Contreras-Vidal; Jason Brandt; Bradley D Hatfield Journal: Biol Psychol Date: 2008-03-02 Impact factor: 3.251